Form 4: Fulgent Genetics CEO Ming Hsieh Sells Shares to Cover Tax Obligations

Fulgent Genetics CEO Ming Hsieh sold 2,313 shares of common stock on August 27, 2024, to cover tax obligations arising from the vesting of restricted stock units.

Summary

• On August 27, 2024, Ming Hsieh, the CEO of Fulgent Genetics, sold 2,313 shares of the company's common stock.
• The sale was executed at a weighted-average price of $22.833 per share, with individual transactions ranging from $22.72 to $22.915.
• The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock units granted to Mr. Hsieh on February 23, 2023.
• Following the transaction, Mr. Hsieh directly owns 707,275 shares.
• Mr. Hsieh also has indirect ownership through the Dynasty Trust (220,816 shares), The Ming Hsieh Trust (7,895,115 shares), and Uniform Transfer to Minors Accounts (2,000 shares).

Sentiment

Score: 5

Explanation: The document describes a routine transaction (selling shares to cover taxes). It doesn't indicate positive or negative sentiment.

Industry Context

This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when restricted stock units vest.

Stakeholder Impact

• The sale of shares by the CEO could have a minor impact on shareholders due to the slight dilution of shares.

Key Dates